tiprankstipranks
Trending News
More News >

Guangzhou Baiyunshan Subsidiary Receives Approval for Production License Changes

Story Highlights
  • Guangzhou Baiyunshan operates in the pharmaceutical industry, producing various medications.
  • The company received approval to reduce production scope, potentially improving efficiency.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Guangzhou Baiyunshan Subsidiary Receives Approval for Production License Changes

Confident Investing Starts Here:

Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an update.

Guangzhou Baiyunshan Pharmaceutical Holdings Company announced that its subsidiary, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., received approval from the Guangdong Provincial Drug Administration for changes to its ‘Drug Production License’. The approval allows the subsidiary to reduce its production scope, workshops, and production lines, which could streamline operations and potentially impact its manufacturing efficiency and cost structure.

More about Guangzhou Baiyunshan Pharmaceutical Holdings Company

Guangzhou Baiyunshan Pharmaceutical Holdings Company operates in the pharmaceutical industry, focusing on the production and distribution of various medications, including tablets, capsules, and injections. The company is known for its extensive range of pharmaceutical products and its market presence in China.

YTD Price Performance: 3.49%

Average Trading Volume: 30,548

Technical Sentiment Signal: Buy

Current Market Cap: $5.52B

See more data about 0874 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App